Study of the Acceptability and Psychosocial Impact of Using a Telepresence Robot in the Living Space of Inpatients

NCT ID: NCT04899830

Last Updated: 2023-02-08

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Clinical Phase

NA

Total Enrollment

16 participants

Study Classification

INTERVENTIONAL

Study Start Date

2020-10-24

Study Completion Date

2024-09-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This study focuses on the mobile robot assist device for tele-interaction: the "COVEALINK 2" robot. This telepresence robot is designed for remote use inside the home. It works with an Internet connection (Wifi or 4G). It consists of a control interface (an application installed on the smartphone or tablet of the hospitalized patient) and a mobile robot placed in the home of the hospitalized patient (composed of a mobile platform, a visualization screen whose tilt is adjustable remotely for better adaptation to the interlocutors and an audio communication system). From the app installed on his smartphone or tablet, the patient hospitalized in the center for a long time (2 months minimum) will be able to start remotely (from the center where he is hospitalized) the robot and have it move within his home to communicate with the people present at the time of use (family, friends, neighbors etc.).

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Motor Disorders Cognitive Disability

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NA

Intervention Model

SINGLE_GROUP

Primary Study Purpose

OTHER

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Installation of a telepresence robot in the home of a disabled person hospitalized in a PRM center

From the application installed on a tablet, the patient hospitalized in a center for a period of at least 2 months can start from the center where he is hospitalized the mobile robotic telepresence assistance device installed at home to communicate with his family, his friends, his neighbors,…)

Group Type EXPERIMENTAL

Telepresence robot

Intervention Type DEVICE

From the application installed on a tablet, the patient hospitalized in a center for a period of at least 2 months can start from the center where he is hospitalized the mobile robotic telepresence assistance device installed at home to communicate with his family, his friends, his neighbors,…)

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Telepresence robot

From the application installed on a tablet, the patient hospitalized in a center for a period of at least 2 months can start from the center where he is hospitalized the mobile robotic telepresence assistance device installed at home to communicate with his family, his friends, his neighbors,…)

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Age ≧ 18 years old
* Affiliation to a social security scheme or beneficiary of such a scheme
* Having signed a free informed consent in writing
* Hospitalized in PRM for a foreseeable period of at least 60 days
* Living space compatible with the movement of the robot (verified by a home visit by the center's occupational therapist) and equipped with wifi
* Cognitive and motor functions compatible with the use of the tablet or phone independently, with learning capabilities to use the robot and the completion of questionnaires and interviews remotely
* Medically stable

Exclusion Criteria

* Subject being in a period of exclusion from another protocol
* Mood and behavior disorders not stabilized
* Insufficient command of the French language
* Protected adults (guardianship / curatorship)
* Pregnant or breastfeeding women
* Persons deprived of their liberty
* Being unable to issue their consent
* Person who has already presented a form of addiction to technologies and / or video games
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

LP3C, University of Rennes 2

UNKNOWN

Sponsor Role collaborator

COVEA

UNKNOWN

Sponsor Role collaborator

Association APPROCHE

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Thibaud Honoré, Doctor

Role: PRINCIPAL_INVESTIGATOR

CMRRF de Kerpape

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

CR Mulhouse

Mulhouse, Alsace, France

Site Status RECRUITING

IUR Clémenceau

Strasbourg, Alsace, France

Site Status ACTIVE_NOT_RECRUITING

CMRRF de Kerpape

Ploemeur, Brittany Region, France

Site Status RECRUITING

CMPR Côte d'Amour

Saint-Nazaire, Pays de la Loire Region, France

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

France

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Marie-Caroline Delebecque, CRA

Role: CONTACT

0297826174 ext. +33

Pauline Coignard, Doctor

Role: CONTACT

0297826060 ext. +33

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Mélanie Fimbel

Role: primary

03 89 32 4646

Marie-Caroline Delebecque, CRA

Role: primary

0297826174

Karine Mathieu

Role: primary

02 40 00 01 00

Hélène Joly Jehenne

Role: backup

02 40 00 01 00

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

2019-A02088-49

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Telerehabilitation Early After CNS Injury
NCT06069999 ACTIVE_NOT_RECRUITING NA
On-Premise and Remote Robotic Neurointervention
NCT06365554 NOT_YET_RECRUITING NA